technews.itfreetools.com

IndiGo faces turbulence ahead; Kaynes Tech emerges as value buy after 50% crash: Sudip Bandyopadhyay

• The Economic Times

IndiGo faces turbulence ahead; Kaynes Tech emerges as value buy after 50% crash: Sudip Bandyopadhyay

Aris December 10, 2025

Market expert Sudip Bandyopadhyay says IndiGo’s 20% fall is not yet a buying opportunity as regulatory action...

Read More Read more about IndiGo faces turbulence ahead; Kaynes Tech emerges as value buy after 50% crash: Sudip Bandyopadhyay

SpiceJet shares surge nearly 20% in 4 sessions. What’s fuelling the rally today?

• The Economic Times

SpiceJet shares surge nearly 20% in 4 sessions. What’s fuelling the rally today?

Aris December 10, 2025

SpiceJet shares climbed significantly on Wednesday. This rise follows IndiGo’s directive to reduce its flight schedule due...

Read More Read more about SpiceJet shares surge nearly 20% in 4 sessions. What’s fuelling the rally today?

Aequs shares list at 13% premium over IPO price on bourses

• The Economic Times

Aequs shares list at 13% premium over IPO price on bourses

Aris December 10, 2025

Aequs shares listed at a 12.9% premium on the bourses on Wednesday, reflecting strong investor appetite after...

Read More Read more about Aequs shares list at 13% premium over IPO price on bourses

Meesho shares dazzle on debut, list at 46% premium over IPO price

• The Economic Times

Meesho shares dazzle on debut, list at 46% premium over IPO price

Aris December 10, 2025

Meesho shares surged 46% on their Dalal Street debut, listing at a significant premium to their IPO...

Read More Read more about Meesho shares dazzle on debut, list at 46% premium over IPO price

Trump set to finalise Fed pick; Hassett, Warsh among top contenders

• The Economic Times

Trump set to finalise Fed pick; Hassett, Warsh among top contenders

Aris December 10, 2025

The White House is nearing a decision on the next Federal Reserve chair, with Kevin Hassett emerging...

Read More Read more about Trump set to finalise Fed pick; Hassett, Warsh among top contenders

Rs 23,000 crore in a month: How an Asia fund became silent winner in India's hottest IPO streak

• The Economic Times

Rs 23,000 crore in a month: How an Asia fund became silent winner in India's hottest IPO streak

Aris December 10, 2025

Peak XV Partners, formerly Sequoia India, is reaping significant rewards from India’s recent IPO surge. Four key...

Read More Read more about Rs 23,000 crore in a month: How an Asia fund became silent winner in India's hottest IPO streak

India's worst smallcap crash in 7 years begs the question: Will 2026 be even worse?

• The Economic Times

India's worst smallcap crash in 7 years begs the question: Will 2026 be even worse?

Aris December 10, 2025

India’s smallcap market experienced its worst crash in seven years, down 9.45% in 2025 after surging in...

Read More Read more about India's worst smallcap crash in 7 years begs the question: Will 2026 be even worse?

Rupee falls 20 paise to 90.07 against US dollar in early trade

• The Economic Times

Rupee falls 20 paise to 90.07 against US dollar in early trade

Aris December 10, 2025

The Indian rupee weakened by 20 paise to 90.07 against the US dollar today, influenced by import...

Read More Read more about Rupee falls 20 paise to 90.07 against US dollar in early trade

Bitcoin FOMO trickles back at $94K, but Fed could spoil the party

• Cointelegraph

Bitcoin FOMO trickles back at $94K, but Fed could spoil the party

Aris December 10, 2025

Bitcoin surged to $94,625, its highest in three weeks, as positive social sentiment returned, but comments from...

Read More Read more about Bitcoin FOMO trickles back at $94K, but Fed could spoil the party

Corona Remedies IPO Day 3: Demand stays strong as GMP hits 25%; should investors apply?

• The Economic Times

Corona Remedies IPO Day 3: Demand stays strong as GMP hits 25%; should investors apply?

Aris December 10, 2025

Corona Remedies’ Rs 655.37-crore IPO has seen strong demand, with overall subscription at 9.33 times by Day...

Read More Read more about Corona Remedies IPO Day 3: Demand stays strong as GMP hits 25%; should investors apply?